title: [Paraparesis as the main manifestation of brucellosis].
authors.forename: M B
authors.initials: MB
authors.lastname: Gómez
authors.forename: M J
authors.initials: MJ
authors.lastname: Miravet
authors.forename: R
authors.initials: R
authors.lastname: Vilaplana
authors.forename: A J
authors.initials: AJ
authors.lastname: Marín
authors.forename: J
authors.initials: J
authors.lastname: Sánchez
authors.forename: A
authors.initials: A
authors.lastname: Pérez
authors.forename: J
authors.initials: J
authors.lastname: Piqueras
mesh_terms: D000293:Adolescent; D000372:Agglutination Tests; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002006:Brucellosis / Q000134:cerebrospinal fluid / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D002555:Cerebrospinal Fluid / Q000166:cytology; D004172:Diplopia / Q000209:etiology; D006261:Headache / Q000209:etiology; D006801:Humans; D008297:Male; D010264:Paraplegia / Q000209:etiology*; D011129:Polyradiculoneuropathy / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D012395:Rose Bengal
chemical_list: D000900:Anti-Bacterial Agents; D012395:Rose Bengal; D011241:Prednisone; D012293:Rifampin
vernacular_title: Paraparesia como principal manifestación de una brucelosis.